Phathom Pharmaceuticals (PHAT) Earnings Date, Estimates & Call Transcripts $4.34 -0.43 (-9.01%) As of 12:57 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Phathom Pharmaceuticals Earnings Summary Upcoming Q4 Earnings DateMay. 8Before Market OpensEstimatedConsensus EPS (Nov. 7) -$1.57 Actual EPS (Nov. 7) -$1.32 Beat By $0.25 Actual Revenue (Nov. 7) $16.35MPhathom Pharmaceuticals announced Q3 2024 earnings on November 7, 2024, reporting an EPS of -$1.32, which topped analysts' consensus estimates of -$1.57 by $0.25. Quarterly revenue was reported to be $16.35 million, above analyst estimates of $12.54 million. With a trailing EPS of -$5.35, Phathom Pharmaceuticals' earnings are expected to grow next year, from ($4.78) to ($4.02) per share. Q3 2024 Earnings ResourcesQ3 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)PHAT Upcoming EarningsPhathom Pharmaceuticals' Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Phathom Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Phathom Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPHAT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PHAT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Phathom Pharmaceuticals Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($4.78) EPSNext Year EPS Consensus Estimate ($4.02) EPS Remove Ads Phathom Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------11/7/2024Q3 2024-$1.57-$1.32+$0.25-$1.32$12.54M$16.35M8/8/2024Q2 2024-$1.39-$1.35+$0.04-$1.14$5.65M$7.32M5/9/2024Q1 2024-$1.43-$1.42+$0.01-$1.42$2.76M$1.91M3/7/2024Q4 2023-$0.92-$0.80+$0.12-$0.21$0.93M$0.68M11/9/2023Q3 2023-$0.95-$0.76+$0.19-$0.76--8/10/2023Q2 2023-$0.95-$0.84+$0.11-$0.84--5/10/2023Q1 2023-$1.34-$0.89+$0.45-$0.89-- Phathom Pharmaceuticals Earnings - Frequently Asked Questions When is Phathom Pharmaceuticals's earnings date? Phathom Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on PHAT's earnings history. Did Phathom Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Phathom Pharmaceuticals (NASDAQ:PHAT) reported ($1.32) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.57) by $0.25. Learn more on analysts' earnings estimate vs. PHAT's actual earnings. How can I listen to Phathom Pharmaceuticals's earnings conference call? The conference call for Phathom Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Phathom Pharmaceuticals's conference call transcript? The conference call transcript for Phathom Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Phathom Pharmaceuticals generate each year? Phathom Pharmaceuticals (NASDAQ:PHAT) has a recorded annual revenue of $55.25 million. How much profit does Phathom Pharmaceuticals generate each year? Phathom Pharmaceuticals (NASDAQ:PHAT) has a recorded net income of -$201.59 million. PHAT has generated -$5.35 earnings per share over the last four quarters. What is Phathom Pharmaceuticals's EPS forecast for next year? Phathom Pharmaceuticals's earnings are expected to grow from ($4.78) per share to ($4.02) per share in the next year. More Earnings Resources from MarketBeat Related Companies IRON Earnings Results TVTX Earnings Results SDGR Earnings Results IDYA Earnings Results IMCR Earnings Results INDV Earnings Results CGON Earnings Results VERA Earnings Results SPRY Earnings Results EWTX Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s Next Remove Ads This page (NASDAQ:PHAT) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phathom Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phathom Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PHAT Stock Free PHAT Stock Alerts